Study of Bortezomib (BTZ) Treatment on Mantle Cell Lymphoma (MCL) in Chinese Participants
Clinical trial NCT03053024 · COMPLETED
Trial details
- NCT number
- NCT03053024
- Sponsor
- Xian-Janssen Pharmaceutical Ltd.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2017-04-14
- Primary completion
- 2019-09-30
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.